Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer

Clinical trial NCT04927780 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04927780
Sponsor: Erasmus Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pancreatic Cancer Pancreatic Ductal Adenocarcinoma Resectable Pancreatic Adenocarcinoma

Start date: 2021-09-07
Primary completion: 2027-01-01
Enrollment: 378

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.